On January 26, 2023 Agenus (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, reported that Dr. Garo Armen, Chairman and CEO, and Dr. Steven O’Day, Chief Medical Officer, will participate in the following upcoming investor conferences (Press release, Agenus, JAN 26, 2023, View Source [SID1234626601]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 5th Annual Oncology Day – Fireside chat presentation will be held in-person on Thursday, February 9th, 2023 at 9:35 AM ET
SVB Securities Global Biopharma Conference – Fireside chat presentation will be held virtually on Thursday, February 16th, 2023 at 10:00 AM ET
A live webcast of the presentations from Guggenheim and SVB Securities conferences can be accessed on the company’s website at View Source A replay will be posted following the event.